american academy of cardiology glp-1 Cardiovascular Disease: ACC Guidelines for Use to Lower Risk Frontiers | Glucagon-like peptide-1 receptor

GLP-1 weight loss tracker: 12 week GLP-1 weight loss tracker for me

Worldwide, nearly 40% of adults are overweight and 13% are obese

Get answers to frequently asked questions about RYBELSUS (semaglutide), a GLP-1 pill for type 2 diabetes

Andy's journey to GLP-1s: Although he was reluctant

The results of cardiovascular and kidney outcomes trials involving sodiumglucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, including assessment of subgroups, inform broader recommendations for cardiorenal protection in people with diabetes at high risk of cardiorenal disease

GLP-1(28-36)amide, a C-terminal nonapeptide of GLP-1, is a major product derived from the cleavage of GLP-1 by the neutral endopeptidase (NEP)